[1] LOMAS R, CHANDRASEKAR A, BOARD TN. Bone allograft in the UK: perceptions and realities.Hip Int. 2013;23(5): 427-433.
[2] STERNHEIM A, DREXLER M, KUZYK PR, et al. Treatment of failed allograft prosthesis composites used for hip arthroplasty in the setting of severe proximal femoral bone defects.J Arthroplasty. 2014;29(5):1058-1062.
[3] HERMANSON O. Advances in tissue engineering.Acta Paediatr. 2009;98(10):1699-1699.
[4] KIM HD, AMIRTHALINGAM S, KIM SL, et al. Biomimetic Materials and Fabrication Approaches for Bone Tissue Engineering.Adv Healthc Mater.2017;6(23):365-377.
[5] TAMIMI F, SHEIKH Z, BARRALET J. Dicalcium phosphate cements: brushite and monetite.Acta Biomater. 2012;8(2): 474-487.
[6] NIDA T, WAI L, GOEBEL W, et al. Fabrication of Poly-l-lactic Acid/Dicalcium Phosphate Dihydrate Composite Scaffolds with High Mechanical, Strength—Implications for Bone Tissue Engineering. J Funct Biomater.2015;6(4):1036-1053.
[7] VAHABZADEN S, ROY M, BOSE S. Effects of silicon on osteoclast cell mediated degradation, in vivo osteogenesis and vasculogenesis of brushite cement.J Mater Chem B. 2015;3(46):8973-8982.
[8] PILMANE M, SALMA-ANCANE K, LOCA D, et al. Strontium and strontium ranelate: Historical review of some of their functions. Mater Sci Eng C Mater Biol Appl. 2017;78:1222-1230.
[9] ALKHRAISAT MH, MOSEKE C, BLANCO L, et al. Strontium modified biocements with zero order release kinetics. Biomaterials.2008;29(35):4691-4697.
[10] PINA S, VIEIRA SI, TORRES PM, et al. In vitro performance assessment of new brushite-forming Zn- and ZnSr-substituted beta-TCP bone cements.J biomed Mater Res B Appl biomater.2010;94(2):414-420.
[11] PINA S, TORRES PM, FERREIRA JM. Injectability of brushite-forming Mg-substituted and Sr-substituted α-TCP bone cements.J Mater Sci Mater Med.2010;21(2):431-438.
[12] LILLEY KJ, GBURECK U, KNOWLES JC, et al. Cement from magnesium substituted hydroxyapatite. J Mater Sci Mater Med.2005;16(5):455-460.
[13] 方俊,董伟,彭宏峰,等.掺锶透钙磷石骨水泥修复骨质疏松家兔牙槽骨缺损的实验研究[J].实用医学杂志,2018,34(5):720-724.
[14] 李淑静.掺锶透钙磷石骨水泥修复骨质疏松骨缺损的实验研究[D].唐山:华北理工大学,2017.
[15] 周秋娟,梁永强,李淑静,等.掺锶透钙磷石骨水泥修复家兔牙槽骨缺损的研究[J].安徽医科大学学报,2017,52(4):589-592.
[16] 闫玉婷.掺锶透钙磷石骨水泥修复牙槽骨缺损的实验研究[D].唐山:华北理工大学,2016.
[17] GARCÍA-GARETA E,COATHUP MJ,BLUNN GW. Osteoinduction of bone grafting materials for bone repair and regeneration.Bone.2015;81:112-121.
[18] ROY A, JHUNJHUNWALA S, BAYER E, et al. Porous calcium phosphate-poly (lactic-co-glycolic) acid composite bone cement: A viable tunable drug delivery system.Mater Sci Eng C Mater Biol Appl. 2016;59:92-101.
[19] KIKUCHI M, MATSUMOTO HN, YAMADA T, et al. Glutaraldehyde cross-linked hydroxyapatite/collagen self-organized nanocomposites.Biomaterials.2004;25(1): 63-69.
[20] SILVA SS, JOÃO FM, REIS RL. Potential applications of natural origin polymer-based systems in soft tissue regeneration. Crit Rev Biotechnol.2010;30(3):200-221.
[21] RAMMELT S, SCHULZE E, BERNHARDT R, et al. Coating of titanium implants with type-I collagen. J Orthop Res. 2004; 22(5):1025-1034.
[22] WANG W, YEUNG KWK. Bone grafts and biomaterials substitutes for bone defect repair: A review.Bioact Mater. 2017; 2(4):224-247.
[23] CHEN M, SONG K, RAO N, et al. Effect of bone marrow mesenchymal stem cells transfected with rAAV2-bFGF on early angiogenesis of calvarial defects in rats.J Huazhong Univ Sci Technolog Med Sci.2010;30(4):519-524.
[24] KERAMARIS NC, CALORI GM, NIKOLAOU VS, et al. Fracture vascularity and bone healing: A systematic review of the role of VEGF.Injury.2008;39(2):S45-S57.
[25] SHUANG Y, YIZHEN L, ZHANG Y, et al. In vitro characterization of an osteoinductive biphasic calcium phosphate in combination with recombinant BMP2. BMC Oral Health. 2016;17(1):35-44.
[26] YONGSUN K, BYUNG-JAE K, WAN K, et al. Evaluation of Mesenchymal Stem Cell Sheets Overexpressing BMP-7 in Canine Critical-Sized Bone Defects.Int J Mol Sci. 2018;19(7): 2073-2086.
[27] 谢程欣,胡庄明,王维,等.重组人骨形态发生蛋白2在四肢骨创伤中的应用:深入探讨理想载体及最佳剂量等问题[J].中国组织工程研究,2019,23(30):4882-4888.
[28] ZHENG Y, WU G, ZHAO J, et al. rhBMP2/7 Heterodimer: An Osteoblastogenesis Inducer of Not Higher Potency but Lower Effective Concentration Compared with rhBMP2 and rhBMP7 Homodimers. Tissue Eng Part A.2010;16(3):879-887.
[29] WANG J, ZHENG Y, ZHAO J, et al. Low-dose rhBMP2/7 heterodimer to reconstruct peri-implant bone defects: A micro-CT evaluation.J Clin Periodontol.2011;39(1):98-105.
[30] 贾婉萍,梁立硕,冯凯悦,等.掺镁透钙磷石对骨质疏松兔骨缺损的成骨效果[J].山西医科大学学报,2017,48(12):1260-1264.
[31] KOTSAR A, NIEMINEN R, ISOTALO T, et al. Biocompatibility of New Drug-eluting Biodegradable Urethral Stent Materials. Urology.2009;75(1):229-234.
[32] ORYAN A, BIGHAM-SADEGH A, ABBASI-TESHNIZI F. Effects of osteogenic medium on healing of the experimental critical bone defect in a rabbit model.Bone.2014;63:53-60.
[33] MCGOVERN JA, GRIFFIN M, HUTMACHER DW. Animal models for bone tissue engineering and modelling disease. Dis Model Mech.2018;11(4):33-84.
[34] 鄂玲玲,王东胜,师占平,等.一种新型的兔牙槽骨缺损模型的建立[J].中华老年口腔医学杂志,2011,9(3):137-140.
[35] HOLLINGER JO, KLEINSCHMIDT JC. The critical size defect as an experimental model to test bone repair materials. J Craniofac Sur.1990;1(1):60-80.
[36] SCHMITZ JP, HOLLINGER JO. The critical size defect as an experimental model for craniomandibulofacial nonunions.Clin Orthop Relat Res.1986;205:299-304.
[37] 程谷.运用不同的接种方法构建组织工程化骨修复颌骨缺损的实验研究[D].武汉:武汉大学,2016.
[38] BOHNER M, LOOSLI Y, BAROUD G, et al. Commentary: Deciphering the link between architecture and biological response of a bone graft substitute.Acta Biomater. 2011;7(2): 478-484.
[39] LU JX, FLAUTRE B, ANSELME K, et al. Role of Interconnections in Porous Bioceramics on Bone Recolonization In Vitro and In Vivo.J Mater Sci Mater Med. 1999;10(2):111-120.
[40] 张单单.明胶的戊二醛、转谷氨酰胺酶改性与性能研究[D].北京:北京工商大学,2016.
[41] GOTHARD D, SMITH EL, KANCZLER JM, et al. Tissue engineered bone using select growth factors: A comprehensive review of animal studies and clinical translation studies in man.Eur Cell Mater. 2014;28(28): 166-208.
[42] YUAN S, PAN Q, LIU W, et al. Recombinant BMP 4/7 fusion protein induces differentiation of bone marrow stem cells.J Cell Biochem.2011;112(10):3054-3060.
[43] KANEKO H, ARAKAWA T, MANO H, et al. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone.2000; 27(4):479-486.
[44] SANDHU H. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.Spine (Phila Pa 1976). 2002; 27(23):2662-2673.
[45] GUO J, WU G. The signaling and functions of heterodimeric bone morphogenetic proteins.Cytokine Growth Factor Rev. 2012;23(1-2):61-67.
[46] KAITO T, MORIMOTO T, MORI Y, et al. BMP-2/7 heterodimer strongly induces bone regeneration in the absence of increased soft tissue inflammation.Spine J. 2017;18(1): 139-146.
[47] SUN P, WANG J, ZHENG Y, et al. BMP2/7 heterodimer is a stronger inducer of bone regeneration in peri-implant bone defects model than BMP2 or BMP7 homodimer.Dental Mate J.2012; 31(2):239-248.
[48] ISRAEL DI, NOVE J, KERNS KM, et al. Heterodimeric Bone Morphogenetic Proteins Show Enhanced Activity In Vitro and In Vivo.Growth Factors.1996;13(3):291-300.
[49] OXLUND H, MOSEKILDE L, ORTOFT G. Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis.Bone. 1996;19(5):479-484.
[50] 梁立硕,贾婉萍,方俊,等.不同浓度掺镁透钙磷石骨水泥修复骨质疏松家兔骨缺损及BMP-2表达的实验研究[J].科学技术与工程, 2018,18(8):187-190.
|